291 related articles for article (PubMed ID: 33747513)
1. A case of durvalumab-induced lichenoid eruption evolving to bullous eruption after phototherapy: A case report.
Manko S; Côté B; Provost N
SAGE Open Med Case Rep; 2021; 9():2050313X21993279. PubMed ID: 33747513
[TBL] [Abstract][Full Text] [Related]
2. Lichen-planus-pemphigoides-like reaction to PD-1 checkpoint blockade.
Wat M; Mollanazar NK; Ellebrecht CT; Forrestel A; Elenitsas R; Chu EY
J Cutan Pathol; 2022 Nov; 49(11):978-987. PubMed ID: 36054729
[TBL] [Abstract][Full Text] [Related]
3. A case of severe nivolumab-induced lichen planus pemphigoides in a child with metastatic spitzoid melanoma.
Mueller KA; Cordisco MR; Scott GA; Plovanich ME
Pediatr Dermatol; 2023 Jan; 40(1):154-156. PubMed ID: 35882548
[TBL] [Abstract][Full Text] [Related]
4. [Simvastatin-induced lichen planus pemphigoides].
Stoebner PE; Michot C; Ligeron C; Durand L; Meynadier J; Meunier L
Ann Dermatol Venereol; 2003 Feb; 130(2 Pt 1):187-90. PubMed ID: 12671581
[TBL] [Abstract][Full Text] [Related]
5. [Coexistence of lichen planus and bullous pemphigoid (an immunofluorescence study of a "lichen pemphigoides") (author's transl)].
Saurat JH; Guinepain MT; Didierjean L; Sohier J; Puissant A
Ann Dermatol Venereol; 1977 May; 104(5):368-74. PubMed ID: 72516
[TBL] [Abstract][Full Text] [Related]
6. Lichen planus pemphigoides: A unique form of bullous and lichenoid eruptions secondary to nivolumab.
Shah RR; Bhate C; Hernandez A; Ho CH
Dermatol Ther; 2022 May; 35(5):e15432. PubMed ID: 35266258
[TBL] [Abstract][Full Text] [Related]
7. Diffuse lichen planus-like keratoses and clinical pseudo-progression associated with avelumab treatment for Merkel cell carcinoma, a case report.
Cardis MA; Jiang H; Strauss J; Gulley JL; Brownell I
BMC Cancer; 2019 Jun; 19(1):539. PubMed ID: 31164102
[TBL] [Abstract][Full Text] [Related]
8. Nivolumab-induced lichen planus pemphigoides.
Strickley JD; Vence LM; Burton SK; Callen JP
Cutis; 2019 Apr; 103(4):224-226. PubMed ID: 31116807
[TBL] [Abstract][Full Text] [Related]
9. Lichen Planus Pemphigoides Associated With PD-1 and PD-L1 Inhibitors: A Case Series and Review of the Literature.
Boyle MM; Ashi S; Puiu T; Reimer D; Sokumbi O; Soltani K; Onajin O
Am J Dermatopathol; 2022 May; 44(5):360-367. PubMed ID: 35120032
[TBL] [Abstract][Full Text] [Related]
10. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features.
Tetzlaff MT; Nagarajan P; Chon S; Huen A; Diab A; Omar P; Aung PP; Torres-Cabala CA; Mays SR; Prieto VG; Curry JL
Am J Dermatopathol; 2017 Feb; 39(2):121-129. PubMed ID: 28134729
[TBL] [Abstract][Full Text] [Related]
11. Lichen planus pemphigoides. Immunofluorescence findings.
Sobel S; Miller R; Shatin H
Arch Dermatol; 1976 Sep; 112(9):1280-3. PubMed ID: 999306
[TBL] [Abstract][Full Text] [Related]
12. Lichen Planopilaris Pemphigoides: A Novel Bullous Dermatosis Due to Programmed Cell Death Protein-1 Inhibitor Therapy.
Liu SS; Howard T; Fattah YH; Adams A; Hanly AJ; Karai LJ
Am J Dermatopathol; 2023 Apr; 45(4):246-249. PubMed ID: 36825932
[TBL] [Abstract][Full Text] [Related]
13. Atorvastatin-induced Lichenoid Drug Eruption: A Case Report and Review of Statin-associated Cutaneous Adverse Events.
Forouzan P; Riahi RR; Cohen PR
Cureus; 2020 Mar; 12(3):e7155. PubMed ID: 32257699
[TBL] [Abstract][Full Text] [Related]
14. Narrowband UVB-induced lichen planus pemphigoide.
Mandy Chan WM; Lee JS; Thiam Theng CS; Chua SH; Boon Oon HH
Dermatol Reports; 2011 Oct; 3(3):e43. PubMed ID: 25386295
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune bullous dermatoses in cancer patients treated by immunotherapy: a literature review and Italian multicentric experience.
Merli M; Accorinti M; Romagnuolo M; Marzano A; Di Zenzo G; Moro F; Antiga E; Maglie R; Cozzani E; Parodi A; Gasparini G; Sollena P; De Simone C; Caproni M; Pisano L; Fattore D; Balestri R; Sena P; Vezzoli P; Teoli M; Ardigò M; Vassallo C; Michelerio A; Satta RR; Dika E; Melotti B; Ribero S; Quaglino P
Front Med (Lausanne); 2023; 10():1208418. PubMed ID: 37547602
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab-Induced Lichenoid Dermatitis in a Patient With Metastatic Cancer of Unknown Primary.
Sethi A; Raj M
Cureus; 2021 Mar; 13(3):e13768. PubMed ID: 33842144
[TBL] [Abstract][Full Text] [Related]
17. Bullous lichen planus and anti-programmed cell death-1 therapy: Case report and literature review.
de Lorenzi C; André R; Vuilleumier A; Kaya G; Abosaleh M
Ann Dermatol Venereol; 2020 Mar; 147(3):221-227. PubMed ID: 31982173
[TBL] [Abstract][Full Text] [Related]
18. Durvalumab-induced de novo annular psoriasiform drug eruption successfully treated with a combination of narrowband ultraviolet B phototherapy and topical treatment.
Lin WH; Lee KY; Lee WR; Shih YH
J Dermatol; 2020 Sep; 47(9):1041-1045. PubMed ID: 32613632
[TBL] [Abstract][Full Text] [Related]
19. Childhood lichen planus pemphigoides: a case report and review of the literature.
Cohen DM; Ben-Amitai D; Feinmesser M; Zvulunov A
Pediatr Dermatol; 2009; 26(5):569-74. PubMed ID: 19840313
[TBL] [Abstract][Full Text] [Related]
20. Pembrolizumab-induced pseudoepitheliomatous eruption consistent with hypertrophic lichen planus.
Coscarart A; Martel J; Lee MP; Wang AR
J Cutan Pathol; 2020 Mar; 47(3):275-279. PubMed ID: 31589773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
